Sign up to see all 5.
Sign up to see all 5.
A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
B
BlackRock, Inc.
|
1.4M | 10.83% | −145.2K (−9.1%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding1.8M (Q3'24)
Change over 8 quarters−314.9K
Share of the company10.830%
|
||||||
|
CP
Caligan Partners LP
13D · 10.0%
|
1.4M | 10.72% | Unchanged | 2022 | 1.0% | |
|
Shares held by quarter
Peak holding1.4M (Q3'24)
Change over 8 quarters0
Share of the company10.720%
Disclosed stake13D · 10.0%
|
||||||
28 more super investors behind a free account
See every manager holding Anika Therapeutics Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$5.82M | 397.8K | 2.97% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$4.55M | 311.3K | 2.33% | 0.01% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Anika Therapeutics Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DJ
David Johnson
5%+ holder
13D · 10.0%
|
1.4M | 10.72% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
BC
Blanchard Cheryl R
Insider
|
270.5K | 2.02% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company2.020%
|
||||||
12 more holders behind a free account
See every insider and 5%+ holder of Anika Therapeutics Inc.
Sign up freeLoading...